S-palmitoylation modulates human estrogen receptor-α functions

Biochemical and Biophysical Research Communications

Volumn 316, Issue 3, 2004, Pages 878-883

  Acconcia, Filippo ^a   Ascenzi, Paolo ^a   Fabozzi, Giulia ^b   Visca, Paolo ^a,b   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

ERK; Estrogen receptor ; Membrane estrogen receptor; S palmitoylation; Transcriptional activity

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DNA BINDING; GENE DELETION; GENE LOCATION; GENE MUTATION; GENETIC TRANSFECTION; GENOMICS; HELA CELL; HUMAN; HUMAN CELL; LIGAND BINDING; PALMITOYLATION; PRIORITY JOURNAL; TRANSACTIVATION; WILD TYPE;

ALANINE; BLOTTING, WESTERN; CELL MEMBRANE; CYSTEINE; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; GENE DELETION; HELA CELLS; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOBLOTTING; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS, SITE-DIRECTED; MUTATION; PALMITIC ACID; PLASMIDS; PRECIPITIN TESTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 1642329884     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.129     Document Type: Article

References (36)

1. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 231:1986;1150-1154.
2. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.-Å. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β Endocrinology. 139:1998;4252-4263.
3. Matthews J., Gustafsson J.-Å. Estrogen signalling: a subtle balance between ERα and ERβ Mol. Intervent. 3:2003;281-292.
4. Dan P., Cheung J.C., Scriven D.R., Moore E.D. Epitope-dependent localization of estrogen receptor-α, but not -β, in en face arterial endothelium. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H1295-H1306.
5. Levin E.R. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol. Metab. 10:1999;374-377.
6. Razandi M., Pedram A., Greene G.L., Levin E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13:1999;307-319.
7. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 407:2000;538-541.
8. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., Han K., Di Gregorio G.B., Katzenellenbogen J.A., Katzenellenbogen B.S., Robertson P.K., Weinstein R.S., Jilka R.L., Manolagas S.C. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 104:2001;719-730.
9. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M. Neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology. 142:2001;969-973.
10. Marino M., Pallottini V., Trentalance A. Estrogens cause rapid activation of IP3-PKC-α signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Commun. 245:1998;254-258.
11. Marino M., Distefano E., Pallottini V., Caporali S., Ceracchi G., Trentalance A. β-estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells. J. Cell. Physiol. 188:2001;170-177.
12. 3 mediate the estrogen receptor activity expressed in human cells. Mol. Cell. Endocrinol. 182:2001;19-26.
13. 1 gene transcription in HepG2 cells. Mol. Biol. Cell. 13:2002;3720-3729.
14. Marino M., Acconcia F., Trentalance A. Biphasic estradiol-induced Akt-phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol. Biol. Cell. 14:2003;2583-2591.
15. Razandi M., Oh P., Pedram A., Schnitzer J., Levin E.R. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16:2002;100-115.
16. Kelly M.J., Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12:2001;152-156.
17. Jakacka M., Ito M., Martinson F., Ishikawa T., Lee E.J., Jameson J.L. An estrogen receptor ERα deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16:2002;2188-2201.
18. Toran-Allerand C.D., Guan X., MacLusky N.J., Horvath T.L., Diano S., Singh M., Connolly E.S. Jr., Nethrapalli I.S., Tinnikov A.A. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22:2002;8391-8401.
19. Li L., Haynes M.P., Bender J.R. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. USA. 100:2003;4807-4812.
20. Dunphy J.T., Linder M.E. Signalling functions of protein palmitoylation. Biochim. Biophys. Acta. 1436:1998;245-261.
21. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta. 1451:1999;1-16.
22. Bijlmakers M.J., Marsh M. The on-off story of protein palmitoylation. Trends Cell Biol. 13:2003;32-42.
23. Varner A.S., Ducker C.E., Xia Z., Zhuang Y., De Vos M.L., Smith C.D. Characterization of human palmitoyl-acyl transferase activity using peptides that mimic distinct palmitoylation motifs. Biochem. J. 373:2003;91-99.
24. Acconcia F., Bocedi A., Ascenzi P., Marino M. Does palmitoylation target estrogen receptors to plasma membrane caveolae? IUBMB Life. 55:2003;33-35.
25. 1 promoter. Oncogene. 9:1994;1295-1304.
26. Kunkel T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA. 82:1985;488-492.
27. Han J.M., Kim Y., Lee J.S., Lee C.S., Lee B.D., Ohba M., Kuroki T., Suh P.-G., Ryu S.H. Localization of phospholipase D1 to caveolin-enriched membrane via palmitoylation: implications for epidermal growth factor signalling. Mol. Biol. Cell. 13:2002;3976-3988.
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 772:1976;248-254.
29. Farach-Carson M.C., Davis P.J. Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J. Pharmacol. Exper. Therap. 307:2003;839-845.
30. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83:2003;965-1016.
31. Pedram A., Razandi M., Aitkenhead M., Hughes C.C., Levin E.R. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J. Biol. Chem. 277:2002;50768-50775.
32. Acconcia F., Marino M. Synergism between genomic and non-genomic estrogen action mechanisms. IUBMB Life. 55:2003;145-150.
33. Patterson S.I. Posttranslational protein S-palmitoylation and the compartmentalization of signaling molecules in neurons. Biol. Res. 35:2002;139-150.
34. Reese J.C., Katzenellenbogen B.S. Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor: studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation. J. Biol. Chem. 267:1992;9868-9873.
35. Aliau S., El Garrouj D., Yasri A., Katzenellenbogen B.S., Borgna J.L. 17α-(Haloacetamidoalkyl)estradiols alkylate the human estrogen receptor at cysteine residues 417 and 530. Biochemistry. 36:1997;5861-5867.
36. Marino M., Ficca R., Ascenzi P., Trentalance A. Nitric oxide inhibits selectively the 17β-estradiol-induced gene expression without affecting nongenomic events in HeLa cells. Biochem. Biophys. Res. Commun. 286:2001;529-533.